KRASG12C mutation in metastatic colorectal cancer: a new target

被引：1
|
作者：
Ibrahim, Rebecca [1 ]
Saleh, Khalil [1 ]
Chahine, Claude [1 ]
Khoury, Rita [1 ]
Khalife, Nadine [2 ]
Lecesne, Axel [1 ]
机构：
[1] Gustave Roussy Canc Campus, Int Dept, F-94800 Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Head & Neck Oncol, F-94800 Villejuif, France
来源：
FUTURE ONCOLOGY | 2023年 / 19卷 / 24期
关键词：
adagrasib; colorectal cancer; KRAS(G12C) mutation; RAS; sotorasib; INHIBITORS; SOTORASIB;
D O I：
10.2217/fon-2023-0223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1641 / 1643
页数：3
相关论文
共 50 条
  • [1] Assessment of KRASG12C inhibitors for colorectal cancer
    Piazza, Gary A.
    Chandrasekaran, Preethi
    Maxuitenko, Yulia Y.
    Budhwani, Karim I.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
    Amodio, Vito
    Yaeger, Rona
    Arcella, Pamela
    Cancelliere, Carlotta
    Lamba, Simona
    Lorenzato, Annalisa
    Arena, Sabrina
    Montone, Monica
    Mussolin, Benedetta
    Bian, Yu
    Whaley, Adele
    Pinnelli, Marika
    Murciano-Goroff, Yonina R.
    Vakiani, Efsevia
    Valeri, Nicola
    Liao, Wei-Li
    Bhalkikar, Anuja
    Thyparambil, Sheeno
    Zhao, Hui-Yong
    de Stanchina, Elisa
    Marsoni, Silvia
    Siena, Salvatore
    Bertotti, Andrea
    Trusolino, Livio
    Li, Bob T.
    Rosen, Neal
    Di Nicolantonio, Federica
    Bardelli, Alberto
    Misale, Sandra
    CANCER DISCOVERY, 2020, 10 (08) : 1129 - 1139
  • [3] Overcoming Resistance to Drugs Targeting KRASG12C Mutation
    Jiao, Delong
    Yang, Shengyu
    INNOVATION, 2020, 1 (02):
  • [4] Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
    Chour, Ali
    Toffart, Anne-Claire
    Berton, Elodie
    Duruisseaux, Michael
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation
    De, Surya K.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (03) : 266 - 272
  • [6] Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
    Sisler, Daniel J.
    Hinz, Trista K.
    Le, Anh T.
    Kleczko, Emily K.
    Nemenoff, Raphael A.
    Heasley, Lynn E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Activity and resistance to KRASG12C G12C inhibitors in non-small cell lung cancer and colorectal cancer
    Ye, Wei
    Lu, Xin
    Qiao, Yue
    Ou, Wen-Bin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [8] KRASG12C inhibitors on the horizon
    Cagir, Ali
    Azmi, Asfar S.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 923 - 925
  • [9] The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
    Kwan, Albert K.
    Piazza, Gary A.
    Keeton, Adam B.
    Leite, Caio A.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [10] Advances in the treatment of KRASG12C mutant non-small cell lung cancer
    Shaverdashvili, Khvaramze
    Burns, Timothy F.
    CANCER, 2025, 131
12345